Breathwork-assisted Treatment for Cannabis Use Disorder
NCT ID: NCT05219825
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
10 participants
INTERVENTIONAL
2022-02-06
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Marijuana Treatment Project 4
NCT02030665
Cannabis Use Disorder Treatment Study
NCT04567394
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
NCT01875796
Cannabis Reduction and Functional Outcomes
NCT07218471
Facilitating the Behavioral Treatment of Cannabis Use Disorder
NCT02946489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breathwork group
Treatment-seeking individuals with cannabis use disorder who will participate in the 1-week breathwork workshop.
Breathwork workshop
Participants will complete 1.5 hours of breathwork session in addition to a total of 6 hours of brief psychotherapeutic intervention in a span of 1 week. The therapy sessions will occur both before and after the breathing session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breathwork workshop
Participants will complete 1.5 hours of breathwork session in addition to a total of 6 hours of brief psychotherapeutic intervention in a span of 1 week. The therapy sessions will occur both before and after the breathing session.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria for active cannabis use disorder.
* Seeking treatment for their cannabis use
Exclusion Criteria
* Active substance use disorder except for cannabis, nicotine, and caffeine.
* History of severe withdrawal symptoms (i.e withdrawal seizures).
* History of dementia, epilepsy or seizures, cardiac arrhythmia, pacemaker/defibrillator, heart failure, asthma, panic disorder and other respiratory illnesses (ie: COPD).
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Elias Dakwar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elias Dakwar
Associate Professor of Clinical Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silvia J Franco Corso, M.D
Role: PRINCIPAL_INVESTIGATOR
New York State Psychiatric Institute/ Columbia University Medical Center
Elias Dakwar, M.D
Role: STUDY_CHAIR
New York State Psychiatric Institute/ Columbia University Medical Center
Kate O'Malley, M.A
Role: STUDY_DIRECTOR
New York State Psychiatric Institute/ Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York State Psychiatric Institute
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8165
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.